while improving its 33% share of the market ... because that could draw the ire of the Justice Department ... then, we could have the litigation cloud hanging over our heads
And look what happened to MSFT after the Justice Dept. got their claws into 'em. Well, okay bad example.
Also, stop using red herrings, you sly dog, in an attempt to confuse. The REAL issue isn't cash flow, it's just cash. Now the way I figure it, $2 billion is a little tight, look at MRK at $3 billion, now there's a 'strong' company. Don't try to obfuscate the issue with jabs like Merck's market cap is 6.5x times AMAT's or that they're in totally different industries (given big Pharmaceuticals' need to be cash rich) ... bottom line is there's a relative cash crunch and if Feds make a move do you realize that cash is now worth more?? That's right! It's complicated (derivatives, etc.) so I won't go into detail here, but from a very technical perspective, if they tried to buy stuff after a hike, they could get more stuff. The idea that greenbacks are worth less in an inflationary environment is misguided, since dollars are worth more (can be 'lent out' at higher rates) after a hike. Clear?
Luckily, at least, AMAT is not in a dividend paying mode, could be the kiss of death. Be afraid, be very afraid.
RO |
